Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer

Παρόμοια τεκμήρια

• Selective RET kinase inhibition for patients with RET-altered cancers
  ανά: Subbiah, V, κ.ά.
  Έκδοση: (2018)
• RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies
  ανά: Solomon, Benjamin J., κ.ά.
  Έκδοση: (2020)
• Targeting RET-rearranged lung cancers with multikinase inhibitors
  ανά: Sabari, Joshua K., κ.ά.
  Έκδοση: (2017)
• Identification of a lung adenocarcinoma cell line with CCDC6‐RET fusion gene and the effect of RET inhibitors in vitro and in vivo
  ανά: Suzuki, Makito, κ.ά.
  Έκδοση: (2013)
• A secondary RET mutation in the activation loop conferring resistance to vandetanib
  ανά: Nakaoku, Takashi, κ.ά.
  Έκδοση: (2018)